We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Zydus Cadila has received final approval from the US Food and Drug Administration (FDA) to market Nelarabine injection 250mg/50ml in the US. Zydus was granted a Competitive Generic Therapy (CGT) designation...